BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23012795)

  • 1. [Mineralocorticoid receptor: an update].
    Nagase M
    Nihon Rinsho; 2012 Sep; 70(9):1504-9. PubMed ID: 23012795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone: The Missing Cardiorenal Link.
    Williams GH
    Am J Nephrol; 2019; 50(5):329-332. PubMed ID: 31661688
    [No Abstract]   [Full Text] [Related]  

  • 3. Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome.
    Nagase M
    Clin Exp Nephrol; 2010 Aug; 14(4):303-14. PubMed ID: 20533072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoid receptor activation in myocardial infarction and failure: recent advances.
    Galuppo P; Bauersachs J
    Eur J Clin Invest; 2012 Oct; 42(10):1112-20. PubMed ID: 22536780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoid receptors in the pathophysiology of chronic kidney diseases and the metabolic syndrome.
    Shibata S; Fujita T
    Mol Cell Endocrinol; 2012 Mar; 350(2):273-80. PubMed ID: 21820485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases.
    Bauersachs J; Jaisser F; Toto R
    Hypertension; 2015 Feb; 65(2):257-63. PubMed ID: 25368026
    [No Abstract]   [Full Text] [Related]  

  • 7. Aldosterone, oxidative stress, and NF-κB activation in hypertension-related cardiovascular and renal diseases.
    Queisser N; Schupp N
    Free Radic Biol Med; 2012 Jul; 53(2):314-27. PubMed ID: 22609249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone and mineralocorticoid receptors in the cardiovascular system.
    Funder JW
    Prog Cardiovasc Dis; 2010; 52(5):393-400. PubMed ID: 20226957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone and the kidney.
    Fourkiotis VG; Hanslik G; Hanusch F; Lepenies J; Quinkler M
    Horm Metab Res; 2012 Mar; 44(3):194-201. PubMed ID: 22161301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation.
    Young MJ
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):174-80. PubMed ID: 18277151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Roles of the Mineralocorticoid Receptor in Pathology: Toward New Paradigms in Clinical Pharmacology.
    Jaisser F; Farman N
    Pharmacol Rev; 2016 Jan; 68(1):49-75. PubMed ID: 26668301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone, mineralocorticoid receptors and vascular inflammation.
    Funder JW
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):263-9. PubMed ID: 15134827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone, mineralocorticoid receptor, and heart failure.
    Messaoudi S; Azibani F; Delcayre C; Jaisser F
    Mol Cell Endocrinol; 2012 Mar; 350(2):266-72. PubMed ID: 21784127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoids in the heart and vasculature: new insights for old hormones.
    Lother A; Moser M; Bode C; Feldman RD; Hein L
    Annu Rev Pharmacol Toxicol; 2015; 55():289-312. PubMed ID: 25251996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic targeting of aldosterone: a novel approach to the treatment of glomerular disease.
    Brem AS; Gong R
    Clin Sci (Lond); 2015 May; 128(9):527-35. PubMed ID: 25671776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the mineralocorticoid receptor in cardiovascular disease.
    Young MJ
    Expert Opin Ther Targets; 2013 Mar; 17(3):321-31. PubMed ID: 23324064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease.
    Bertocchio JP; Warnock DG; Jaisser F
    Kidney Int; 2011 May; 79(10):1051-60. PubMed ID: 21412221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mineralocorticoid receptor activation in obesity hypertension.
    Nagase M; Fujita T
    Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineralocorticoid receptor activation and cardiac fibrosis.
    Young MJ; Lam EY; Rickard AJ
    Clin Sci (Lond); 2007 Jul; 112(9):467-75. PubMed ID: 17391102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mineralocorticoid receptor activation as an etiological factor in kidney diseases.
    Ueda K; Nagase M
    Clin Exp Nephrol; 2014 Feb; 18(1):16-23. PubMed ID: 23832326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.